Page last updated: 2024-08-22

gadolinium and losartan potassium

gadolinium has been researched along with losartan potassium in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Condorelli, M; Genovese, A; Marone, G; Peschle, C; Rappaport, IA	1
Hellman, RN	1
Galaria, N; Gust, A; Hanjani, NM; Poggioli, G; Pryor, JG; Robison, J; Samie, F; Scott, GA	1
Chan, BP; Goveia, M; Patel, PR	1
Shah, SV; Swaminathan, S	1
Bennett, CL; Bookstaver, PB; Cournoyer, D; Cowper, S; Kahn, A; Locatelli, F; Lopez, I; Luminari, S; Macdougall, IC; Mattison, DR; Miller, AD; Murday, A; Norris, LB; Qureshi, ZP; Ray, P; Sartor, O; Starko, KM; Thomsen, HS; Trenery, A; Xirasagar, S	1

Reviews

2 review(s) available for gadolinium and losartan potassium

Article	Year
New insights into nephrogenic systemic fibrosis. Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:10 Topics: Blood Vessels; Erythropoietin; Fibrosis; Gadolinium; Humans; Inflammation; Iron; Renal Insufficiency	2007
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). Journal of general internal medicine, 2012, Volume: 27, Issue:12 Topics: Aspirin; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Female; Gadolinium; Humans; Male; Nephrogenic Fibrosing Dermopathy; Prevalence; Prognosis; Red-Cell Aplasia, Pure; Reye Syndrome; Risk Assessment; South Carolina; Survival Rate	2012

Article

Year

New insights into nephrogenic systemic fibrosis.

Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:10

Topics: Blood Vessels; Erythropoietin; Fibrosis; Gadolinium; Humans; Inflammation; Iron; Renal Insufficiency

2007

Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).

Journal of general internal medicine, 2012, Volume: 27, Issue:12

Topics: Aspirin; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Female; Gadolinium; Humans; Male; Nephrogenic Fibrosing Dermopathy; Prevalence; Prognosis; Red-Cell Aplasia, Pure; Reye Syndrome; Risk Assessment; South Carolina; Survival Rate

2012

Other Studies

4 other study(ies) available for gadolinium and losartan potassium

Article	Year
Increased erythropoietin production in anephric rats with hyperplasia of the reticuloendothelial system induced by colloidal carbon or zymosan. Blood, 1976, Volume: 47, Issue:2 Topics: Animals; Carbon; Colloids; Erythropoietin; Female; Gadolinium; Hepatectomy; Hyperplasia; Hypoxia; Liver; Male; Mice; Mononuclear Phagocyte System; Nephrectomy; Organ Size; Rats; Zymosan	1976
Erythropoietin, gadolinium, and nephrogenic fibrosing dermopathy. Annals of internal medicine, 2007, Feb-06, Volume: 146, Issue:3 Topics: Erythropoietin; Fibrosis; Gadolinium; Humans; Recombinant Proteins; Renal Insufficiency; Skin Diseases	2007
Nephrogenic systemic fibrosis: a clinicopathologic study of six cases. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:1 Topics: Adult; Aged; Contrast Media; Erythropoietin; Female; Fibrosis; Gadolinium; Humans; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Skin Diseases; Surgical Procedures, Operative	2007
Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:4 Topics: Adult; Case-Control Studies; Drug Interactions; Erythropoietin; Female; Fibrosis; Gadolinium; Hematinics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Radiopharmaceuticals; Recombinant Proteins; Risk Factors; Skin; Skin Diseases	2007